Science Explorer Back to mapMap
Discussion
Researcher · Arizona Oncology · United States

Sudhir Manda

Sudhir Manda publishes mostly in Hematology, Oncology and Molecular Biology, on topics such as Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research and Protein Degradation and Inhibitors.

OpenAlex
World rank
#2,880,680
of 7,710,434 ranked researchers
Rank in United States
#832,266
of 1,627,098
Works
58
Citations
706
Citations per work
12.2
h-index
12
i10-index 14Top 49% in Hematology
Sudhir Manda

What does Sudhir Manda research?

Sudhir Manda's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (13%).

Health Sciences: 36 works · 62.2% of their workMedicine: 36 works · 62.2% of their workHematology: 11 works · 18.6% of their workOncology: 10 works · 17.9% of their workGenetics: 6 works · 10.9% of their workPathology and Forensic Medicine: 4 works · 7.7% of their workRadiology, Nuclear Medicine and Imaging: 4 works · 7.1% of their workEverything else: 14 works · 25.0% of their workLife Sciences: 7 works · 12.8% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 12.8% of their workMolecular Biology: 7 works · 12.8% of their workTHEIR WORKSudhir Manda58works
Life Sciences13%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3662.2%
  2. Everything else1425.0%
    1. Biochemistry, Genetics and Molecular Biology712.8%
  1. 1Hematology19% of their works
  2. 2Oncology18% of their works
  3. 3Molecular Biology13% of their works
  4. 4Genetics11% of their works
  5. 5Pathology and Forensic Medicine8% of their works
  6. 6Radiology, Nuclear Medicine and Imaging7% of their works

Research topics

Which keywords describe Sudhir Manda's research?

The keywords of their largest research topics: Rituximab, Diagnosis Criteria, International Myeloma Working Group, Chronic Lymphocytic Leukemia, Genomic Aberrations, PET Imaging, BET Bromodomains and Lymphoma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Rituximab262 topics
  2. Diagnosis Criteria221 topic
  3. International Myeloma Working Group221 topic
  4. Chronic Lymphocytic Leukemia171 topic
  5. Genomic Aberrations171 topic
  6. PET Imaging152 topics
  7. BET Bromodomains131 topic
  8. Lymphoma132 topics
  9. PROTACs131 topic
  10. Tumor Microenvironment112 topics
  11. Classification91 topic
  12. Molecular Profiling91 topic
  13. Fibroblast Activation Protein61 topic
  14. Immunosuppression61 topic
  15. Immune Checkpoint Blockade51 topic
  16. PD-1 and PD-L151 topic
  17. BCR-ABL41 topic
  18. CAR T Cells41 topic
  19. Chimeric Antigen Receptor41 topic
  20. Imatinib41 topic

Where does Sudhir Manda work?

Sudhir Manda's main affiliation in the publication record is Arizona Oncology, United States.

How many publications and citations does Sudhir Manda have?

OpenAlex counts 58 works and 706 citations for Sudhir Manda, an h-index of 12, ranking #2,880,680 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sudhir Manda. Posts are plain text and can be reported.